Carraguard (PC-515)

DRUG6 trials

Sponsors

Population Council

Conditions

AIDSChlamydia TrachomatisHIV InfectionsHIV SeroconversionHerpes SimplexNeisseria GonorrhoeaeNesseria GonorrheaSexually Transmitted Diseases

Phase 1

A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women

CompletedNCT00213044

Population CouncilHIV Infections

Start: 2003-03-31End: 2004-06-30Target: 60Updated: 2017-08-15

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

CompletedNCT00213005

Population CouncilHIV Infections

Start: 2002-06-30End: 2003-08-31Target: 60Updated: 2017-08-14

Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand

CompletedNCT00213057

Population CouncilChlamydia Trachomatis, HIV Infections, Nesseria Gonorrhea +2

Start: 2001-06-30End: 2002-06-30Target: 110Updated: 2017-08-14

Phase 2

Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

CompletedNCT00213031

Population CouncilChlamydia Trachomatis, Herpes Simplex, HIV Infections +3

Start: 2000-02-29End: 2001-12-31Target: 165Updated: 2017-08-14

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

CompletedNCT00213018

Population CouncilChlamydia Trachomatis, HIV Infections, Neisseria Gonorrhoeae +2

Start: 1999-10-31End: 2002-01-31Target: 400Updated: 2017-08-14

Phase 3

Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission

CompletedNCT00213083

Population CouncilAIDS, HIV Infections, HIV Seroconversion +1

Start: 2004-04-30End: 2007-04-30Updated: 2017-08-15

Related Papers

Acceptability of Carraguard vaginal microbicide gel among HIV-infected women in Chiang Rai, Thailand.

2011-09-0717 citations

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

2008-12-01368 citations